1.Optimal dose of gamma irradiation for the prevention of transfusion-associated graft-versus-host disease.
Dae Won KIM ; Eun Suk KANG ; Hyun Suk CHI ; Won Ki MIN ; Chowl Won SUH
Korean Journal of Blood Transfusion 1993;4(1):67-74
No abstract available.
Graft vs Host Disease*
2.Chronic Cutaneous Graft versus Host Disease Mimicking Warts.
Bo In LEE ; Young Min PARK ; Hyung Ok KIM ; Jun Young LEE
Annals of Dermatology 2015;27(1):90-92
No abstract available.
Graft vs Host Disease*
;
Warts*
4.Acute Graft-versus-Host Disease after Liver Transplantation.
Hyunju JIN ; Hyunho CHO ; Wonjeong KIM ; Jeho MUN ; Margaret SONG ; Hoon Soo KIM ; Byung Soo KIM ; Moon Bum KIM ; Hyun Chang KO
Korean Journal of Dermatology 2014;52(10):761-763
No abstract available.
Graft vs Host Disease*
;
Liver Transplantation*
5.Graft-versus-Host Disease: Report of Four Cases.
Jong Yuk YI ; Baik Kee CHO ; Won HOUH ; Chong Won PARK ; Choon Choo KIM
Annals of Dermatology 1989;1(1):21-27
No abstract available.
Graft vs Host Disease*
;
HLA-DR Antigens
6.Acute Cutaneous Graft-Versus-Host Reaction.
Annals of Dermatology 1997;9(2):77-86
Graft-versus-host disease occurs after the administration of foreign immunologically competent cells to an individual who is immunologically compromised. It is a clinical syndrome characterized by cutaneous changes, gastrointestinal dysfunction and liver dysfunction. Cutaneous graft-versus-host reaction is usually the earliest and certainly the most common form of the disease. The diagnosis of graft-versus-host disease is a complex clinicopathologic skill requiring considerable experience. There as yet appears to be no pathognomonic single clinical or histologic feature in the acute phase. In this review article, the definition, immunological aspects and. clinical features of graft-versus-host disease, diagnostic criteria of acute cutaneous graft-versus-host reaction and graft-versus-tumor effect are discussed.
Diagnosis
;
Graft vs Host Disease
;
Liver Diseases
7.The role of B cells in acute graft-versus-host disease.
Byung Sik CHO ; Nak Gyun CHUNG
Korean Journal of Hematology 2011;46(4):287-288
No abstract available.
B-Lymphocytes
;
Graft vs Host Disease
8.NKT cells and graft-versus-host disease-review.
Lei ZHAO ; Sha HAO ; Wei-Ping YUAN ; Tao CHENG
Journal of Experimental Hematology 2013;21(5):1345-1350
NKT cells (nature killer T cells), as a regulatory cellular compartment in the immune system, express cell surface markers of T cells and NK cells. It secretes a variety of cytokines that stimulate specific antigens. Through regulating the balance of Th1/Th2, the NKT cells play an important role in prevention and treatment of graft-versus-host disease (GVHD). Its antitumor and anti-infectious effects serve as a basis of its application in allogeneic hematopoietic stem cell transplantation. A better understanding of the biological and immunological features of NKT cell, as well as its specific immune regulatory mechanisms, will further justify the rationales of using NKT cells in the management of GVHD for patients. In this review, the biologic properties, classification, differentiation and development, immune activation of NKT cells as well as the NKT cells and GVHD including the related mechanisms of prevention and treatment of GVHD with NKT cells, NKT cells and tumors, NKT cells and infection, and NKT cells and clinical GVHD are summarized.
Animals
;
Graft vs Host Disease
;
Humans
;
Natural Killer T-Cells
Result Analysis
Print
Save
E-mail